返回 Agenda
LS20 New Phase in Combatting Antimicrobial Resistance (AMR)
Session Chair(s)
Masahito Nagashima
Head of Clinical Research
Pfizer R&D Japan, Japan
Speaker(s)
Shigeru Omi, MD, PhD
Japan Anti-Tuberculosis Association, Japan
Representative Director
Kazuhiro Tateda, MD, PhD
Toho University, Japan
Professor, Department of Microbiology and Infectious Diseases
Mari Ariyasu
Shionogi & Co., Ltd., Japan
Head of Project Management 4, Senior Director